In homogeneous catalysis, the catalyst is in the same phase as the reactant. The number of collisions between reactants and catalyst is at a maximum.In a patent, 1317-39-1, name is Copper(I) oxide, introducing its new discovery. Formula: Cu2O
Dibenzo[b,d]thiopyran derivatives, pharmaceutical composition and use
The invention relates to compounds having the general formula (I) STR1 wherein R1 is carboxy, esterified carboxy or an amide of formula STR2 in which R9 is hydrogen or C1 -C6 alkyl, A is C2 -C6 alkylene and Ra and Rb are hydrogen or C1 -C6 alkyl or Ra and Rb taken together with the nitrogen atom to which they are linked form a saturated, optionally substituted, heteromonocyclic ring; R2 is hydrogen or C1 -C6 alkyl; each of R3 to R8 is independently hydrogen, halogen, C1 -C6 -alkyl, C3 -C4 alkenyloxy or C1 -C6 alkoxy; and the pharmaceutically acceptable salts thereof, which are useful as immunomodulating and anti-viral agents.
We¡¯ll also look at important developments in the pharmaceutical industry because understanding organic chemistry is important in understanding health, medicine, the role of 1317-39-1, and how the biochemistry of the body works.Formula: Cu2O
Reference£º
Copper catalysis in organic synthesis – NCBI,
Special Issue “Fundamentals and Applications of Copper-Based Catalysts”